These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28934848)

  • 1. Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.
    Lee JH; Kim YH; Kim KH; Cho JY; Woo SM; Yoo BC; Kim SC
    Cancer Res Treat; 2018 Jul; 50(3):883-893. PubMed ID: 28934848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
    Lee JH; Yoo BC; Kim YH; Ahn SA; Yeo SG; Cho JY; Kim KH; Kim SC
    BioData Min; 2016; 9():32. PubMed ID: 27752286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.
    Lee JH; Kim KH; Park JW; Chang HJ; Kim BC; Kim SY; Kim KG; Lee ES; Kim DY; Oh JH; Yoo BC; Kim IH
    Int J Cancer; 2014 Apr; 134(8):1844-53. PubMed ID: 24096867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer.
    Kim SC; Kim MK; Kim YH; Ahn SA; Kim KH; Kim K; Kim WK; Lee JH; Cho JY; Yoo BC
    Oncol Lett; 2014 Aug; 8(2):566-574. PubMed ID: 25013471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
    Tiss A; Timms JF; Smith C; Devetyarov D; Gentry-Maharaj A; Camuzeaux S; Burford B; Nouretdinov I; Ford J; Luo Z; Jacobs I; Menon U; Gammerman A; Cramer R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1518-24. PubMed ID: 21370595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum biomarkers for ovarian cancer using MALDI-TOF-MS combined with magnetic beads.
    Wu S; Xu K; Chen G; Zhang J; Liu Z; Xie X
    Int J Clin Oncol; 2012 Apr; 17(2):89-95. PubMed ID: 21638024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
    Park CW; Jo Y; Jo EJ
    Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer.
    Timms JF; Cramer R; Camuzeaux S; Tiss A; Smith C; Burford B; Nouretdinov I; Devetyarov D; Gentry-Maharaj A; Ford J; Luo Z; Gammerman A; Menon U; Jacobs I
    Clin Chem; 2010 Feb; 56(2):262-71. PubMed ID: 20093557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
    Periyasamy A; Gopisetty G; Veluswami S; Joyimallaya Subramanium M; Thangarajan R
    Biomarkers; 2015; 20(5):292-8. PubMed ID: 26329525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
    Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
    Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
    BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALDI-TOF Mass Spectrometry Based on Parylene-Matrix Chip for the Analysis of Lysophosphatidylcholine in Sepsis Patient Sera.
    Park JM; Noh JY; Kim MJ; Yun TG; Lee SG; Chung KS; Lee EH; Shin MH; Ku NS; Yoon S; Kang MJ; Park MS; Pyun JC
    Anal Chem; 2019 Nov; 91(22):14719-14727. PubMed ID: 31621295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare.
    Lee JH; Yu SE; Kim KH; Yu MH; Jeong IH; Cho JY; Park SJ; Lee WJ; Han SS; Kim TH; Hong EK; Woo SM; Yoo BC
    EPMA J; 2018 Sep; 9(3):287-297. PubMed ID: 30174764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip.
    Park JM; Kim MJ; Noh JY; Yun TG; Kang MJ; Lee SG; Yoo BC; Pyun JC
    J Am Soc Mass Spectrom; 2020 Apr; 31(4):917-926. PubMed ID: 32154716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric screening of ovarian cancer with serum glycans.
    Kim JH; Park CW; Um D; Baek KH; Jo Y; An H; Kim Y; Kim TJ
    Dis Markers; 2014; 2014():634289. PubMed ID: 24648610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis.
    Li K; Pei Y; Wu Y; Guo Y; Cui W
    J Ovarian Res; 2020 Jan; 13(1):6. PubMed ID: 31924227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of serum peptide biomarker for ovarian cancer diagnosis by Clin-TOF-II-MS combined with magnetic beads technology].
    Xiu L; Li N; Wang WP; Chen F; Yuan GW; Sun YC; Zhang R; Li XG; Zuo J; Li N; Cui W; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1188-1195. PubMed ID: 34794222
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screen and identification of serum protein biomarkers in gastric cancer].
    Zhang H; Li H; Guo F; Zhang D; Yang H; Wang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Mar; 19(3):317-22. PubMed ID: 27003656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.